Edition: India  
> >

U.S. FDA approves biosimilar version of cancer drug Avastin

Reuters India Thursday, 14 September 2017 ()
(Reuters) - The U.S. Food and Drug Administration said on Thursday it has approved Amgen Inc's biosimilar version of Roche Holding AG's cancer drug Avastin.
Share on
Share on
Post on 
Share by
Source: RTV6 The Indy Channel - < > Embed

News video: Drug tested to lessen chemo side effects at IU Health

Drug tested to lessen chemo side effects at IU Health 01:39

With a $2.9 million grant, the IU Cancer Center has begun testing a new drug to lessen the side effects of chemotherapy. Doctors at the Simon Cancer Center are looking to develop the drug to help cancer patients.

You Might Like

Other recent news in Health

Former 'heaviest woman' EMAN AHMED Abd El Aty diesOBAMACARE repeal on the ropes as pivotal Republican rebuffs Trump
Spokesman says GOP Sen. Rand Paul opposes party's HEALTH CARE bill despite revisions, latest blow to Republican hopesU.S. HEALTHCARE BILL appears doomed after Collins says no
VENEZUELA doctors in protest urge stronger WHO stance on health crisisPUERTO RICO's Arecibo Radio Telescope Suffers Hurricane Damage
In our twisted "progressive" society, what takes real courage is STANDING for the NATIONAL ANTHEM... #BoycottNFLThousands Flee Bali's MOUNT AGUNG After Volcano Threat Level Is Raised
Coffee sold in CALIFORNIA could carry cancer warning labels


Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2017 newsR / One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter